Biosimilars – Market Events And Forecast – Ophthalmology

In 2019, sales of branded biologics in ophthalmology reached almost $9 billion across the major markets (United States, EU5, and Japan). Throughout our 2019-2029 forecast period, reference brands Lucentis (ranibizumab) and Eylea (aflibercept) are set to lose patent protection, with biosimilars expected to enter the market and erode both patient share and drug prices. We present our forecasts for these two key reference brands and their biosimilars by molecule and region.

Table of contents

  • Biosimilars - Market Events And Forecast - Ophthalmology
    • Market Forecast in the Major Pharmaceutical Markets
      • Major-Market Forecast: Ophthalmology Biologics
      • Terminology
      • Overarching Forecast Assumptions
        • Overview of Ophthalmology Biological Brands in Forecast
          • Overview of Approved Ophthalmology Biologics
          • Biosimilar Entry Assumptions for Ophthalmology Biologics
        • Overview of Biosimilars in Ophthalmology Disease Assumptions
        • Drug-Specific Forecast Assumptions
          • Lucentis
            • Outlook for Lucentis
            • First Major-Market Biosimilar Entrants
            • Order of Entry in the United States
            • Order of Entry in the EU5
            • Order of Entry in Japan
            • Biosimilar Uptake Assumptions
            • Biosimilar and Brand Ex-Manufacturer Price Assumptions
            • Lucentis Sales Forecast for the United States: 2019-2029
            • Lucentis Sales Forecast for the EU5: 2019-2029
            • Lucentis Sales Forecast for Japan: 2019-2029
          • Eylea
            • Outlook for Eylea
            • First Major-Market Biosimilar Entrants
            • Order of Entry in the United States
            • Order of Entry in the EU5
            • Order of Entry in Japan
            • Biosimilar Uptake Assumptions
            • Biosimilar and Brand Ex-Manufacturing Price Assumptions
            • Eylea Sales Forecast for the United States: 2019-2029
            • Eylea Sales Forecast for the EU5: 2019-2029
            • Eylea Sales Forecast for Japan: 2019-2029

      launch Related Market Assessment Reports